Free Delivery Over $100
|
|
|||
|
||||
OverviewVolume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology. Full Product DetailsAuthor: Bernard Testa (University Hospital Centre, Lausanne, Switzerland) , Urs A. Meyer (Biocentre, University of Basel, Switzerland)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Volume: v. 26 Dimensions: Width: 15.20cm , Height: 1.80cm , Length: 22.90cm Weight: 0.530kg ISBN: 9780120133260ISBN 10: 0120133261 Pages: 279 Publication Date: 05 September 1995 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: In Print  Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsL.B. Kier and B. Testa, Complexity and Emergence in Drug Research. M.S. Tute, Drug Design: the Present and the Future. K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools. C.L. Crespi, Xenobiotic-metabolizing Human Cells as Tools for Pharmacological and Toxicological Research. J. Urquhart, Correlates of Variable Patient Compliance in Drug Trials: Relevance in the New Health Care Environment. Subject Index. Cumulative Index of Authors. Cumulative Index of Titles.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
